{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:13:21Z","timestamp":1767842001354,"version":"3.49.0"},"reference-count":46,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2000,11,24]]},"published-print":{"date-parts":[[2001,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To examine the number and volume of red blood cell transfusions (RBCTs) in very and extremely low birthweight infants under restrictive red blood cell transfusion guidelines without erythropoietin administration, and to compare the results with those reported in similar infants receiving erythropoietin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec sec-type=\"methods\">\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>From April 1996 to June 1999, all RBCTs given to infants with a birth weight of less than 1500 g were prospectively recorded. Data on RBCT combined with erythropoietin treatment and RBCT guidelines were extracted from four prospective randomised trials of erythropoietin for anaemia of prematurity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>When the restrictive RBCT guidelines were followed, the number of RBCTs and volume transfused were similar to those reported during erythropoietin administration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>RBCT guidelines may have a similar impact on RBCT in very low birthweight infants to the administration of erythropoietin. The effect of RBCT guidelines on RBCT frequency should be considered when evaluating the efficacy of erythropoietin administration to preterm infants.<\/jats:p>\n                  <jats:p>\n                     <jats:boxed-text position=\"float\">\n                        <jats:sec>\n                           <jats:title>Key messages<\/jats:title>\n                           <jats:list list-type=\"simple\">\n                              <jats:list-item>\n                                 <jats:p>Indications for RBCT in preterm infants are controversial<\/jats:p>\n                              <\/jats:list-item>\n                              <jats:list-item>\n                                 <jats:p>RBCT to very low birthweight infants can be reduced to the rate reported during erythropoietin administration if restrictive transfusion guidelines are applied<\/jats:p>\n                              <\/jats:list-item>\n                              <jats:list-item>\n                                 <jats:p>When evaluating trials of erythropoietin administration to reduce RBCT in preterm infants, the effect of the transfusion guidelines applied during these studies should be taken into account<\/jats:p>\n                              <\/jats:list-item>\n                              <jats:list-item>\n                                 <jats:p>Trials on RBCT and erythropoietin administration should focus on long term neurodevelopmental outcome<\/jats:p>\n                              <\/jats:list-item>\n                           <\/jats:list>\n                        <\/jats:sec>\n                     <\/jats:boxed-text>\n                  <\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/fn.84.2.f96","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:40:22Z","timestamp":1027752022000},"page":"F96-F100","source":"Crossref","is-referenced-by-count":64,"title":["Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?"],"prefix":"10.1136","volume":"84","author":[{"given":"A R","family":"Franz","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Division of Neonatology and Paediatric Critical Care, University of Ulm, 89070 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Pohlandt","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Division of Neonatology and Paediatric Critical Care, University of Ulm, 89070 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2001,3,1]]},"reference":[{"key":"2025090513464407000_84.2.F96.1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0095-5108(18)30274-4","article-title":"Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects.","volume":"22","author":"Bifano","year":"1995","journal-title":"Clin Perinatol"},{"key":"2025090513464407000_84.2.F96.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70150-6"},{"key":"2025090513464407000_84.2.F96.3","first-page":"276","article-title":"Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy?","volume":"17","author":"Asch","year":"1997","journal-title":"J Perinatol"},{"key":"2025090513464407000_84.2.F96.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0146-0005(97)80015-8"},{"key":"2025090513464407000_84.2.F96.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70097-6"},{"key":"2025090513464407000_84.2.F96.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.2.194"},{"key":"2025090513464407000_84.2.F96.7","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050641"},{"key":"2025090513464407000_84.2.F96.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70058-1"},{"key":"2025090513464407000_84.2.F96.9","doi-asserted-by":"publisher","DOI":"10.1136\/fn.78.3.F214"},{"key":"2025090513464407000_84.2.F96.10","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050551"},{"key":"2025090513464407000_84.2.F96.11","first-page":"653","article-title":"Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea.","volume":"131","author":"Strauss","year":"1997","journal-title":"J Pediatr"},{"key":"2025090513464407000_84.2.F96.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80223-3"},{"key":"2025090513464407000_84.2.F96.13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM198709173171203","article-title":"Circulating erythroid progenitors in the anemia of prematurity.","volume":"317","author":"Shannon","year":"1987","journal-title":"N Engl J Med"},{"key":"2025090513464407000_84.2.F96.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80303-8"},{"key":"2025090513464407000_84.2.F96.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82488-6"},{"key":"2025090513464407000_84.2.F96.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82552-1"},{"key":"2025090513464407000_84.2.F96.17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1203\/00006450-199311000-00022","article-title":"In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study.","volume":"34","author":"Soubasi","year":"1993","journal-title":"Pediatr Res"},{"key":"2025090513464407000_84.2.F96.18","doi-asserted-by":"publisher","DOI":"10.1136\/adc.69.1_Spec_No.19"},{"key":"2025090513464407000_84.2.F96.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301701"},{"key":"2025090513464407000_84.2.F96.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70089-1"},{"key":"2025090513464407000_84.2.F96.21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1542\/peds.93.6.918","article-title":"Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.","volume":"93","author":"Meyer","year":"1994","journal-title":"Pediatrics"},{"key":"2025090513464407000_84.2.F96.22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.","volume":"95","author":"Shannon","year":"1995","journal-title":"Pediatrics"},{"key":"2025090513464407000_84.2.F96.23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0095-5108(18)30273-2","article-title":"Red blood cell transfusion practices in the neonate.","volume":"22","author":"Strauss","year":"1995","journal-title":"Clin Perinatol"},{"key":"2025090513464407000_84.2.F96.24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.4.700"},{"key":"2025090513464407000_84.2.F96.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70320-8"},{"key":"2025090513464407000_84.2.F96.26","first-page":"81","article-title":"Umbilical venous erythropoietin and umbilical arterial pH in relation to morphologic placental abnormalities.","volume":"84","author":"Maier","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2025090513464407000_84.2.F96.27","first-page":"92","article-title":"Impact of transfusion guidelines on neonatal transfusions.","volume":"18","author":"Alagappan","year":"1998","journal-title":"J Perinatol"},{"key":"2025090513464407000_84.2.F96.28","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1997.02170380031005"},{"key":"2025090513464407000_84.2.F96.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80881-0"},{"key":"2025090513464407000_84.2.F96.30","doi-asserted-by":"publisher","DOI":"10.1136\/adc.60.2.99"},{"key":"2025090513464407000_84.2.F96.31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1818.x"},{"key":"2025090513464407000_84.2.F96.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70362-1"},{"key":"2025090513464407000_84.2.F96.33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0095-5108(18)30930-8","article-title":"Assessment of anemia in newborn infants.","volume":"11","author":"Blanchette","year":"1984","journal-title":"Clin Perinatol"},{"key":"2025090513464407000_84.2.F96.34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0095-5108(18)30272-0","article-title":"Recombinant human erythropoietin in neonatal anemia.","volume":"22","author":"Shannon","year":"1995","journal-title":"Clin Perinatol"},{"key":"2025090513464407000_84.2.F96.35","doi-asserted-by":"crossref","first-page":"F182","DOI":"10.1136\/fn.74.3.F182","article-title":"Factors related to transfusion in very low birthweight infants treated with erythropoietin.","volume":"74","author":"Maier","year":"1996","journal-title":"Arch Dis Child"},{"key":"2025090513464407000_84.2.F96.36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/jpme.1998.26.1.43","article-title":"Low degree of regionalization and high transfusion rates in very low birthweight infants: a survey in Germany.","volume":"26","author":"Maier","year":"1998","journal-title":"J Perinat Med"},{"key":"2025090513464407000_84.2.F96.37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2141.1990.tb07886.x","article-title":"Total circulating red cells versus haematocrit as the primary descriptor of oxygen transport by the blood.","volume":"76","author":"Jones","year":"1990","journal-title":"Br J Haematol"},{"key":"2025090513464407000_84.2.F96.38","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.7_Spec_No.672"},{"key":"2025090513464407000_84.2.F96.39","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199807000-00020"},{"key":"2025090513464407000_84.2.F96.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80389-5"},{"key":"2025090513464407000_84.2.F96.41","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1984.02140470031010"},{"key":"2025090513464407000_84.2.F96.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70351-8"},{"key":"2025090513464407000_84.2.F96.43","doi-asserted-by":"crossref","first-page":"F150","DOI":"10.1136\/fn.82.2.F150","article-title":"Haematocrit and red blood cell transport in preterm infants: an observational study.","volume":"82","author":"Pladys","year":"2000","journal-title":"Arch Dis Child"},{"key":"2025090513464407000_84.2.F96.44","first-page":"235","article-title":"[The critical hemoglobin value in newborn infants, infants and children].","volume":"30","author":"Linderkamp","year":"1992","journal-title":"Beitr Infusionsther"},{"key":"2025090513464407000_84.2.F96.45","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1991.02160070095028"},{"key":"2025090513464407000_84.2.F96.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70037-7"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fn.84.2.F96","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T20:46:55Z","timestamp":1757105215000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/fn.84.2.F96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,3,1]]},"published-print":{"date-parts":[[2001,3,1]]}},"alternative-id":["10.1136\/fn.84.2.F96"],"URL":"https:\/\/doi.org\/10.1136\/fn.84.2.f96","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]}}}